July 12, 2013 — Aspirin has been widely used for more than 50 years as a common, inexpensive blood thinner for patients ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
The year 2013 has brought us several important clinical trials that have changed the way interventional cardiologists ...
May 17, 2013 — Patients with coronary artery disease who undergo treatment at the University of Maryland Medical Center ...
May 16, 2013 — Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug ...
April 30, 2013 — The U.S. Food and Drug Administration (FDA) approved Kcentra (prothrombin complex concentrate, human) ...
April 29, 2013 — A simple self-monitoring test could reduce the risk of stroke by half in thousands of people in the ...
April 25, 2013 — The decision to perform an invasive procedure to open clogged arteries in the heart instead of first ...
April 16, 2013 — Accumetrics Inc. announced an expansion in the intended use for the CE marked VerifyNow P2Y12 Test ...
April 12, 2013 — The U.S. Food and Drug Administration (FDA) issued a second complete response letter regarding a ...
April 12, 2013 — A research study of more than 600 black patients with uncontrolled hypertension found that less than ...
April 5, 2013 — A study led by researchers at the University of North Carolina indicates a newly approved blood thinner ...
April 4, 2013 — Corgenix Medical Corp. has announced that Atherotech Diagnostics Lab will carry its AspirinWorks Test ...
April 4, 2013 — The experimental anti-clotting drug cangrelor solidly outperformed commonly used clopidogrel in a large ...
March 28, 2013 — Cardiologists at ACC.13 learned that patients with coronary artery disease who received a Resolute drug ...
March 25, 2013 — The largest randomized study of the vitamin niacin in patients with occlusive arterial disease has ...